{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:02:09Z","timestamp":1779904929775,"version":"3.53.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02693-6","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:30:14Z","timestamp":1779895814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis"],"prefix":"10.1038","volume":"11","author":[{"given":"Cong-cong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-xing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-6738","authenticated-orcid":false,"given":"Yu-ping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-qun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"2693_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek, I. M., Loring, B. & John, S. M. A systematic review of worldwide epidemiology of psoriasis. J. Eur. Acad. Dermatol. 31, 205 (2017).","journal-title":"J. Eur. Acad. Dermatol."},{"key":"2693_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/bjd\/ljad158","volume":"189","author":"SE Choon","year":"2023","unstructured":"Choon, S. E. et al. Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC(R)) clinical information system from 2010 to 2020. Brit. J. Dermatol. 189, 410 (2023).","journal-title":"Brit. J. Dermatol."},{"key":"2693_CR3","doi-asserted-by":"crossref","unstructured":"Krueger, J. G., McInnes, I. B. & Blauvelt, A. Tyrosine kinase 2 and Janus kinase\u2012signal transducer and activator of transcription signaling and inhibition in plaque psoriasis. J. Am. Acad. Dermatol. 86, 148\u2013157 (2021).","DOI":"10.1016\/j.jaad.2021.06.869"},{"key":"2693_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W. & Read, C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323, 1945 (2020).","journal-title":"JAMA"},{"key":"2693_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866 (2007).","journal-title":"Nature"},{"key":"2693_CR6","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/13543784.2016.1237502","volume":"25","author":"M Campa","year":"2016","unstructured":"Campa, M. & Menter, A. A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies. Expert Opin. Inv. Drug 25, 1337 (2016).","journal-title":"Expert Opin. Inv. Drug"},{"key":"2693_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.581","volume":"10","author":"Q Yu","year":"2022","unstructured":"Yu, Q. et al. Interactions between NLRP3 inflammasome and glycolysis in macrophages: new insights into chronic inflammation pathogenesis. Immun. Inflamm. Dis. 10, e581 (2022).","journal-title":"Immun. Inflamm. Dis."},{"key":"2693_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/ard-2023-224604","volume":"83","author":"KC Binod","year":"2024","unstructured":"Binod, K. C., Jabbour, A., Poudel, P., Banki, K. & Perl, A. IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient. Ann. Rheum. Dis. 83, 265 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"2693_CR9","first-page":"1092","volume":"159","author":"KE Nograles","year":"2008","unstructured":"Nograles, K. E. et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Brit. J. Dermatol. 159, 1092 (2008).","journal-title":"Brit. J. Dermatol."},{"key":"2693_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaci.2023.11.017","volume":"153","author":"L Migayron","year":"2024","unstructured":"Migayron, L., Merhi, R., Seneschal, J. & Boniface, K. Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: appearances can be deceptive. J. Allergy Clin. Immun. 153, 606 (2024).","journal-title":"J. Allergy Clin. Immun."},{"key":"2693_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1191782","volume":"14","author":"V Navarro-Compan","year":"2023","unstructured":"Navarro-Compan, V. et al. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases. Front. Immunol. 14, 1191782 (2023).","journal-title":"Front. Immunol."},{"key":"2693_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/bjd.19325","volume":"183","author":"SK Mahil","year":"2020","unstructured":"Mahil, S. K. et al. Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis. Brit. J. Dermatol. 183, 638 (2020).","journal-title":"Brit. J. Dermatol."},{"key":"2693_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamadermatol.2024.2463","volume":"160","author":"K Eyerich","year":"2024","unstructured":"Eyerich, K. et al. Noninferiority of 16-week vs 8-week guselkumab dosing in super responders for maintaining control of psoriasis: the GUIDE randomized clinical trial. JAMA Dermatol. 160, 953 (2024).","journal-title":"JAMA Dermatol."},{"key":"2693_CR14","doi-asserted-by":"publisher","first-page":"17134","DOI":"10.1038\/s41598-023-44346-6","volume":"13","author":"C He","year":"2023","unstructured":"He, C., Song, T., Qi, R. & Gao, X. Integrated single-cell and spatial transcriptomics reveals heterogeneity of fibroblast and pivotal genes in psoriasis. Sci. Rep. 13, 17134 (2023).","journal-title":"Sci. Rep."},{"key":"2693_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/0929866526666181208170027","volume":"26","author":"N Matsushima","year":"2019","unstructured":"Matsushima, N., Takatsuka, S., Miyashita, H. & Kretsinger, R. H. Leucine rich repeat proteins: sequences, mutations, structures and diseases. Protein Peptide Lett. 26, 108 (2019).","journal-title":"Protein Peptide Lett."},{"key":"2693_CR16","doi-asserted-by":"publisher","first-page":"150785","DOI":"10.1016\/j.bbrc.2024.150785","volume":"734","author":"Y Yamauchi","year":"2024","unstructured":"Yamauchi, Y., Mieno, H., Suetsugu, H., Watanabe, H. & Nakaya, M. Elevated PRELP expression in heart and liver fibrosis promotes collagen production. Biochem. Bioph. Res. Co. 734, 150785 (2024).","journal-title":"Biochem. Bioph. Res. Co."},{"key":"2693_CR17","doi-asserted-by":"publisher","first-page":"154205","DOI":"10.1016\/j.phymed.2022.154205","volume":"104","author":"D Zhang","year":"2022","unstructured":"Zhang, D., Du, J., Yu, M. & Suo, L. Ginsenoside Rb1 prevents osteoporosis via the AHR\/PRELP\/NF-kappaB signaling axis. Phytomedicine 104, 154205 (2022).","journal-title":"Phytomedicine"},{"key":"2693_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01370-z","volume":"14","author":"K Shozu","year":"2022","unstructured":"Shozu, K. et al. Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer. Clin. Epigenetics 14, 147 (2022).","journal-title":"Clin. Epigenetics"},{"key":"2693_CR19","doi-asserted-by":"crossref","unstructured":"Papadaki, V. et al. Two secreted proteoglycans, activators of urothelial cell\u2012cell adhesion, negatively contribute to bladder cancer initiation and progression. Cancers 12, 3362 (2020).","DOI":"10.3390\/cancers12113362"},{"key":"2693_CR20","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"2693_CR21","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.7150\/jca.46309","volume":"11","author":"R Hong","year":"2020","unstructured":"Hong, R. et al. PRELP has prognostic value and regulates cell proliferation and migration in hepatocellular carcinoma. J. Cancer 11, 6376 (2020).","journal-title":"J. Cancer"},{"key":"2693_CR22","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.4049\/jimmunol.1601319","volume":"198","author":"G Liu","year":"2017","unstructured":"Liu, G. et al. PRELP enhances host innate immunity against the respiratory tract pathogen Moraxella catarrhalis. J. Immunol. 198, 2330 (2017).","journal-title":"J. Immunol."},{"key":"2693_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1083\/jcb.200906014","volume":"187","author":"N Rucci","year":"2009","unstructured":"Rucci, N. et al. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis. J. Cell Biol. 187, 669 (2009).","journal-title":"J. Cell Biol."},{"key":"2693_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jid.2015.11.025","volume":"136","author":"H Ray-Jones","year":"2016","unstructured":"Ray-Jones, H., Eyre, S., Barton, A. & Warren, R. B. One SNP at a time: moving beyond GWAS in psoriasis. J. Invest. Dermatol. 136, 567 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"2693_CR25","doi-asserted-by":"publisher","first-page":"103529","DOI":"10.1016\/j.autrev.2024.103529","volume":"23","author":"M Robert","year":"2024","unstructured":"Robert, M. & Miossec, P. Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation. Autoimmun. Rev. 23, 103529 (2024).","journal-title":"Autoimmun. Rev."},{"key":"2693_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/rheumatology\/40.5.522","volume":"40","author":"MC Honorati","year":"2001","unstructured":"Honorati, M. C. et al. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology 40, 522 (2001).","journal-title":"Rheumatology"},{"key":"2693_CR27","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","volume":"129","author":"EG Harper","year":"2009","unstructured":"Harper, E. G. et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest. Dermatol. 129, 2175 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"2693_CR28","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jid.2022.02.016","volume":"142","author":"Z Yu","year":"2022","unstructured":"Yu, Z. et al. IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of YAP-AREG axis. J. Invest. Dermatol. 142, 2343 (2022).","journal-title":"J. Invest. Dermatol."},{"key":"2693_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","volume":"49","author":"M Wang","year":"2018","unstructured":"Wang, M. et al. Gain-of-function mutation of Card14 leads to spontaneous psoriasis-like skin inflammation through enhanced keratinocyte response to IL-17A. Immunity 49, 66 (2018).","journal-title":"Immunity"},{"key":"2693_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","volume":"130","author":"JG Krueger","year":"2012","unstructured":"Krueger, J. G. et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J. Allergy Clin. Immun. 130, 145 (2012).","journal-title":"J. Allergy Clin. Immun."},{"key":"2693_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","volume":"144","author":"JG Krueger","year":"2019","unstructured":"Krueger, J. G. et al. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis. J. Allergy Clin. Immun. 144, 750 (2019).","journal-title":"J. Allergy Clin. Immun."},{"key":"2693_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jaci.2019.10.041","volume":"145","author":"LE Tomalin","year":"2020","unstructured":"Tomalin, L. E. et al. Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis. J. Allergy Clin. Immun. 145, 922 (2020).","journal-title":"J. Allergy Clin. Immun."},{"key":"2693_CR33","doi-asserted-by":"crossref","unstructured":"Hopkins, J. et al. PRELP regulates cell\u2012cell adhesion and EMT and inhibits retinoblastoma progression. Cancers 14 (2022).","DOI":"10.3390\/cancers14194926"},{"key":"2693_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100278","volume":"296","author":"H Kosuge","year":"2021","unstructured":"Kosuge, H. et al. Proteomic identification and validation of novel interactions of the putative tumor suppressor PRELP with membrane proteins including IGFI-R and p75NTR. J. Biol. Chem. 296, 100278 (2021).","journal-title":"J. Biol. Chem."},{"key":"2693_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04476-x","volume":"21","author":"H Schafer","year":"2023","unstructured":"Schafer, H. et al. Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma. J. Transl. Med. 21, 643 (2023).","journal-title":"J. Transl. Med."},{"key":"2693_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10495-024-02015-7","volume":"30","author":"X Li","year":"2025","unstructured":"Li, X. et al. PRELP inhibits colorectal cancer progression by suppressing epithelial\u2013mesenchymal transition and angiogenesis via the inactivation of the FGF1\/PI3K\/AKT pathway. Apoptosis 30, 16 (2025).","journal-title":"Apoptosis"},{"key":"2693_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier, S., Gouwy, M. & Proost, P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts toward pharmacological intervention. Cell Mol. Immunol. 20, 217 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"2693_CR38","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.crimmu.2023.100067","volume":"4","author":"C Dong","year":"2023","unstructured":"Dong, C., Lin, L. & Du, J. Characteristics and sources of tissue-resident memory T cells in psoriasis relapse. Curr. Res. Immunol. 4, 100067 (2023).","journal-title":"Curr. Res. Immunol."},{"key":"2693_CR39","doi-asserted-by":"crossref","unstructured":"Kim, N. Y., Cheong, S. H., Lee, K. J., Sok, D. E. & Kim, M. R. Anti-inflammatory effects of ribes diacanthum pall mediated via regulation of Nrf2\/HO-1 and NF-kappaB signaling pathways in LPS-stimulated RAW 264.7 macrophages and a TPA-induced dermatitis animal model. Antioxidants 9 (2020).","DOI":"10.3390\/antiox9070622"},{"key":"2693_CR40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bjd.20090","volume":"185","author":"M Tollenaere","year":"2021","unstructured":"Tollenaere, M. et al. Signaling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways. Brit. J. Dermatol. 185, 585 (2021).","journal-title":"Brit. J. Dermatol."},{"key":"2693_CR41","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Compan","year":"2021","unstructured":"Navarro-Compan, V., Sepriano, A., El-Zorkany, B. & van der Heijde, D. Axial spondyloarthritis. Ann. Rheum. Dis. 80, 1511 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"2693_CR42","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1053\/j.gastro.2023.01.017","volume":"164","author":"R Gowen","year":"2023","unstructured":"Gowen, R., Gamal, A., Di Martino, L., McCormick, T. S. & Ghannoum, M. A. Modulating the microbiome for Crohn\u2019s disease treatment. Gastroenterology 164, 828 (2023).","journal-title":"Gastroenterology"},{"key":"2693_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep45266","volume":"7","author":"L Ni","year":"2017","unstructured":"Ni, L. et al. The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3. Sci. Rep. 7, 45266 (2017).","journal-title":"Sci. Rep."},{"key":"2693_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0736-2","volume":"16","author":"Y Lei","year":"2017","unstructured":"Lei, Y. et al. Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation. Mol. Cancer 16, 170 (2017).","journal-title":"Mol. Cancer"},{"key":"2693_CR45","doi-asserted-by":"publisher","first-page":"15061","DOI":"10.1074\/jbc.M108285200","volume":"277","author":"E Bengtsson","year":"2002","unstructured":"Bengtsson, E. et al. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J. Biol. Chem. 277, 15061 (2002).","journal-title":"J. Biol. Chem."},{"key":"2693_CR46","doi-asserted-by":"publisher","first-page":"1283383","DOI":"10.1155\/2022\/1283383","volume":"2022","author":"Y Dong","year":"2022","unstructured":"Dong, Y., Zhong, J. & Dong, L. The role of decorin in autoimmune and inflammatory diseases. J. Immunol. Res. 2022, 1283383 (2022).","journal-title":"J. Immunol. Res."},{"key":"2693_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02210-0","volume":"21","author":"S He","year":"2020","unstructured":"He, S. et al. Single-cell transcriptome profiling of an adult human cell atlas of 15 major organs. Genome Biol. 21, 294 (2020).","journal-title":"Genome Biol."},{"key":"2693_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114513","volume":"43","author":"J Jiang","year":"2024","unstructured":"Jiang, J. et al. The mechano-chemical circuit in fibroblasts and dendritic cells drives basal cell proliferation in psoriasis. Cell Rep. 43, 114513 (2024).","journal-title":"Cell Rep."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02693-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:02:25Z","timestamp":1779901345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02693-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2693"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02693-6","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}